
Administration of the Interleukin-1 Inhibitor Canakinumab in Children with Autoinflammatory Diseases and Systemic Juvenile Arthritis: the Report for Case Series
Author(s) -
С. О. Салугина,
М. И. Каледа,
Е. С. Фёдоров,
Iriikishina
Publication year - 2016
Publication title -
voprosy sovremennoj pediatrii
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v15i1.1504
Subject(s) - canakinumab , medicine , tolerability , anakinra , arthritis , dermatology , adverse effect , disease